MBFW
EDIT icon

Morton Brown Family Wealth’s Editas Medicine EDIT Stock Holding History

Morton Brown Family Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65
Closed -$226 – 300
2025
Q3 		$226 Hold
65
– – ﹤0.01% 259
2025
Q2 		$143 Hold
65
– – ﹤0.01% 305
2025
Q1 		$75 Hold
65
– – ﹤0.01% 311
2024
Q4 		$83 Hold
65
– – ﹤0.01% 279
2024
Q3 		$222 Hold
65
– – ﹤0.01% 261
2024
Q2 		$345 Hold
65
– – ﹤0.01% 210
2024
Q1 		$482 Hold
65
– – ﹤0.01% 204
2023
Q4 		$658 Buy
+65
New +$571 ﹤0.01% 265

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morton Brown Family Wealth's EDIT Position: Q4 2025 in Review

Morton Brown Family Wealth sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 65 shares — an estimated $226 sold.

Morton Brown Family Wealth first reported a position in EDIT in Q4 2023 and held it in 8 quarters. The position peaked at $658 in Q4 2023. 196 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Morton Brown Family Wealth reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Morton Brown Family Wealth sold 65 Editas Medicine shares in Q4 2025, an estimated $226.
  • Morton Brown Family Wealth first reported a position in Editas Medicine in Q4 2023 and held it in 8 quarters.
  • Morton Brown Family Wealth's Editas Medicine position peaked at $658 in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Morton Brown Family Wealth's 13F filing for Q4 2025, filed 28 Jan 2026.